STOCK CAPITAL (Tables)

3 Months Ended

Sep. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Composition of Common Stock Capital

	Authorized				Issued and outstanding
	Number of shares
	September 30, 2016		June 30, 2016		September 30, 2016		June 30, 2016
	(unaudited)				(unaudited)
Stock of $0.0001 par value:
Common stock		125,000,000		125,000,000		41,056,801		40,889,922

Schedule of Stock Option Activity

						Weighted
						average
				Weighted		remaining
	Number			average		contractual		Aggregate
	of			exercise		term		intrinsic
	Options			price		in years		Value
Outstanding as of July 1, 2016		4,837,364		$	4.50		6.58	$	74,292
Granted		197,821			16.79
Exercised		(113,691	)		2.39
Forfeited or expired		(13,137	)		5.43
Outstanding as of September 30, 2016		4,908,357			5.05		6.50		61,639
Vested and expected to vest as of September 30, 2016		4,765,530			4.96		6.47		60,199
Exercisable as of September 30, 2016		3,221,141			3.30		5.54		45,316

Schedule of RSU Activity

	No. of RSUs			Weighted averagegrant date fair value
Unvested as of July 1, 2016		834,186			24.74
Granted		666,903			16.50
Vested		(50,547	)		24.58
Forfeited		(16,417	)		22.98
Unvested as of September 30, 2016		1,434,125			20.91

Schedule of Options and RSUs Granted to Non-Employee Consultants

	Outstanding				Exercisable
	as of				as of
Issuance	September 30,		Exercise		September 30,		Exercisable
Date	2016		price		2016		Through
July 31, 2008		33,333		0.87		33,333	July 31, 2018
October 24, 2012		5,166		2.46		5,166	October 24, 2022
January 23, 2013		3,333		3.03		3,194	January 23, 2023
January 27, 2014		4,148		3.51		2,261	January 27, 2024
May 1, 2014		6,000		3.51		3,917	May 1, 2024
September 17, 2014		10,830		3.96		6,142	September 17, 2024
October 29, 2014		5,638		5.01		1,526	October 29, 2024
August 19, 2015		19,834		0.00		-
November 8, 2015		3,501		0.00		-
April 18, 2016		2,292		0.00		-
July 11, 2016		2,667		0.00		-
September 21, 2016		4,000		15.34		-	September 21, 2026
September 21, 2016		7,000		0.00		-
		107,742				55,539

Schedule of Recognized Stock-Based Compensation Expense

	Three months ended September 30, 2016		Three months ended September 30, 2015
Cost of revenues	$	384	$	180
Research and development		927		395
Selling and marketing		850		616
General and administrative		939		641
Total stock-based compensation expense	$	3,100	$	1,832